208 related articles for article (PubMed ID: 22100886)
1. Intradermal fractional dose inactivated polio vaccine: a review of the literature.
Nelson KS; Janssen JM; Troy SB; Maldonado Y
Vaccine; 2012 Jan; 30(2):121-5. PubMed ID: 22100886
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y
J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
4. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
[TBL] [Abstract][Full Text] [Related]
5. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
[TBL] [Abstract][Full Text] [Related]
6. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program.
Shahzad A; Köhler G
Vaccine; 2009 Aug; 27(39):5293-4. PubMed ID: 19638271
[TBL] [Abstract][Full Text] [Related]
8. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
9. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
10. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
11. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
12. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
13. [Inactivated poliovirus vaccine].
Shimizu H
Nihon Rinsho; 2011 Sep; 69(9):1604-8. PubMed ID: 21922761
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of post-polio certification immunization policies.
Sangrujee N; Cáceres VM; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
[TBL] [Abstract][Full Text] [Related]
15. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
Khan MM
Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
[TBL] [Abstract][Full Text] [Related]
16. Possible global strategies for stopping polio vaccination and how they could be harmonized.
Cochi SL; Sutter RW; Aylward RB
Dev Biol (Basel); 2001; 105():153-8; discussion 159. PubMed ID: 11763323
[TBL] [Abstract][Full Text] [Related]
17. Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.
Schoub BD
Vaccine; 2012 Sep; 30 Suppl 3():C35-7. PubMed ID: 22939019
[TBL] [Abstract][Full Text] [Related]
18. Circulating vaccine derived polio viruses and their impact on global polio eradication.
Wagner BG; Earn DJ
Bull Math Biol; 2008 Jan; 70(1):253-80. PubMed ID: 17934778
[TBL] [Abstract][Full Text] [Related]
19. Adjuvants and inactivated polio vaccine: a systematic review.
Hawken J; Troy SB
Vaccine; 2012 Nov; 30(49):6971-9. PubMed ID: 23041122
[TBL] [Abstract][Full Text] [Related]
20. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.
Thompson KM; Duintjer Tebbens RJ
Expert Rev Vaccines; 2014 Feb; 13(2):221-34. PubMed ID: 24308581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
